Our Recommendation
Semilla Nueva is a high‑impact, evidence‑oriented agricultural nutrition organization that combines measurable income gains for farmers with rigorous, counterfactual nutrition evidence for women and children. For funders focused on closing micronutrient gaps and reducing child stunting in maize‑reliant countries, it is an excellent candidate, especially given its strong alignment of farmer incentives (higher yields and profits) with public‑health goals (better nutrition).
Semilla Nueva's Fierce Certification score is 120/100 based on our criteria:
✔ Has Ultimate Outcome Goals (50 pts)
✔ Measures Intermediate Outcomes (10 pts)
✔ Measures Ultimate Outcomes (15 pts)
✔ Shows Continual Learning & Adaptation (25 pts)
✔ Measures Intermediate Counterfactual (10 pts)
✔ Measures Ultimate Counterfactual (10 pts)
The Social Problem
Semilla Nueva targets chronic malnutrition and low farm incomes among maize‑growing families in Guatemala and similar contexts, where maize is the staple food. In these settings, diets dominated by conventional maize lack sufficient zinc, iron, and quality protein, contributing to high rates of stunting, anemia, and poor child development while farmers also struggle with low yields, climate stress, and poverty. Guatemala, for example, faces some of the highest child stunting rates globally, with malnutrition estimated to cost over 9% of GDP in health and lost productivity.
The Solution
Semilla Nueva’s solution is to breed, produce, and scale biofortified, high‑yielding, climate‑resilient maize seeds that significantly improve both farmer livelihoods and family nutrition. It identifies promising varieties from seed banks and companies, crossbreeds them with locally adapted maize that naturally contains more zinc, iron, and quality protein, then partners with seed companies to produce and sell these seeds at prices even the poorest farmers can afford. By working through 1–10 partners per country who each reach 10,000–100,000 farmers, the model is designed to move quickly from improved seeds in fields to nutritious maize on plates for millions of consumers.
Key Outputs
Key outputs give useful context:
- Farmer reach: in 2023, around 24,000–24,500 farming families in Guatemala planted Semilla Nueva’s biofortified maize.
- People reached: biofortified corn improved the nutrition of more than 800,000–825,000 people nationally in 2023.
- Yield and income impacts: farmers paid roughly $25 for seed and saw on average an $182–$190 increase in profits, with productivity up about 18%.
- Nutritional content of seed: new varieties provide about 39% more zinc, 19% more iron, and 30–80% more lysine and tryptophan than standard maize, while matching or exceeding top commercial varieties in yield and climate resilience.
These outputs show a program that is already operating at meaningful scale while maintaining a strong evidence focus.
Key Intermediate Outcomes
Intermediate outcomes with measurement include:
- Increased yields and productivity: Semilla Nueva and external partners report ~18% higher maize productivity for farmers using its seeds compared with standard seeds, based on comparative studies.
- Higher farm profits per hectare: studies comparing users and non‑users show average income gains of ~$182 per farmer family in Guatemala, translating to an 88% income increase, with strong returns on a $25 seed investment.
- Climate‑resilient production: while less quantified, agronomic comparisons indicate that biofortified seeds match or exceed popular varieties in drought and storm resistance, a critical intermediate outcome in climate‑vulnerable regions.
These rely on quasi‑experimental comparisons (biofortified vs standard seeds) rather than simple before‑after tracking.
Key Ultimate Outcomes
Semilla Nueva’s most important ultimate outcomes are nutritional:
- Zinc deficiency elimination: intake modeling suggests that women and children in rural maize‑growing families consuming the biofortified maize fully close their zinc deficiency gaps relative to baseline deficiency rates.
- Iron deficiency reduction: the same analyses estimate iron deficiency is cut by about 50% for children and 100% for women in producing families compared with what would be expected without the new maize.
- Child growth and stunting: the organization points to RCTs of quality‑protein maize, which show increased height and weight gain and significant reductions in child stunting among QPM consumers versus controls, and uses this evidence base to ground its own growth impact assumptions.
Together, these provide counterfactual‑anchored evidence that Semilla Nueva’s approach can materially reduce micronutrient deficiencies and stunting for a large rural population.
Continual Learning & Adaptation
Semilla Nueva demonstrates a strong learning ethos:
- It has iteratively redesigned its seeds and model to better align farmer incentives (taste, yield, climate resilience, price) with nutrition goals, based on farmer feedback and adoption experience.
- It has invested in rigorous measurement and partnered with external evaluators (e.g., UI Charitable, CASE at Duke, Fierce Philanthropy) that highlight its use of RCT evidence and its own intake‑deficiency modeling to sharpen impact estimates.
- It is now working with governments in Guatemala and El Salvador to pilot public‑sector scale‑up of biofortified maize, showing a willingness to adapt from a direct‑delivery social enterprise to a systems partner as evidence and demand grow.
This pattern suggests Semilla Nueva is using evidence not just to prove its model, but to evolve it and embed it into larger systems, in line with our four‑step learning cycle.
Written by
